These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy. Wan X; Song L; Pan W; Zhong H; Li N; Tang B ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253 [TBL] [Abstract][Full Text] [Related]
3. Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy. Hur W; Park Y; Seo E; Son SE; Kim S; Seo H; Seong GH J Colloid Interface Sci; 2023 Sep; 645():663-675. PubMed ID: 37167915 [TBL] [Abstract][Full Text] [Related]
4. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy. Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703 [TBL] [Abstract][Full Text] [Related]
5. Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors. Chen Y; Yao Y; Zhou X; Liao C; Dai X; Liu J; Yu Y; Zhang S ACS Appl Mater Interfaces; 2019 Dec; 11(49):46112-46123. PubMed ID: 31722522 [TBL] [Abstract][Full Text] [Related]
6. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy. Jiang Y; Lu H; Lei L; Yuan X; Scherman D; Liu Y Colloids Surf B Biointerfaces; 2024 Aug; 240():113981. PubMed ID: 38815310 [TBL] [Abstract][Full Text] [Related]
7. Dual-Functional Nanoplatform Based on Bimetallic Metal-Organic Frameworks for Synergistic Starvation and Chemodynamic Therapy. Xiao Y; Lai F; Xu M; Zheng D; Hu Y; Sun M; Lv N ACS Biomater Sci Eng; 2023 Apr; 9(4):1991-2000. PubMed ID: 36989499 [TBL] [Abstract][Full Text] [Related]
8. A cascade-reaction enabled synergistic cancer starvation/ROS-mediated/chemo-therapy with an enzyme modified Fe-based MOF. Liu Z; Li T; Han F; Wang Y; Gan Y; Shi J; Wang T; Akhtar ML; Li Y Biomater Sci; 2019 Aug; 7(9):3683-3692. PubMed ID: 31361291 [TBL] [Abstract][Full Text] [Related]
9. Glucose Oxidase-Modified Metal-Organic Framework for Starving-Enhanced Chemodynamic Therapy. Liu Y; Chen K; Yang Y; Shi P ACS Appl Bio Mater; 2023 Feb; 6(2):857-864. PubMed ID: 36633432 [TBL] [Abstract][Full Text] [Related]
10. An intelligent Cu/ZIF-8-based nanodrug delivery system for tumor-specific and synergistic therapy via tumor microenvironment-responsive cascade reaction. Wei F; Hou L; Yao Y; Lai Y; Lin T; Zhao S; Tang D Mikrochim Acta; 2024 Jul; 191(8):447. PubMed ID: 38963544 [TBL] [Abstract][Full Text] [Related]
11. A multimodal strategy of Fe Zhang Y; Yang Y; Shi J; Wang L Nanoscale; 2021 Oct; 13(39):16571-16588. PubMed ID: 34585187 [TBL] [Abstract][Full Text] [Related]
12. Glucose oxidase-amplified CO generation for synergistic anticancer therapy via manganese carbonyl-caged MOFs. Wang Y; Jing D; Yang J; Zhu S; Shi J; Qin X; Yin W; Wang J; Ding Y; Chen T; Lu B; Yao Y Acta Biomater; 2022 Dec; 154():467-477. PubMed ID: 36244597 [TBL] [Abstract][Full Text] [Related]
13. Manganese-deposited iron oxide promotes tumor-responsive ferroptosis that synergizes the apoptosis of cisplatin. Cheng J; Zhu Y; Xing X; Xiao J; Chen H; Zhang H; Wang D; Zhang Y; Zhang G; Wu Z; Liu Y Theranostics; 2021; 11(11):5418-5429. PubMed ID: 33859755 [No Abstract] [Full Text] [Related]
14. Atomically dispersed bimetallic active sites as H Mao YW; Chu KF; Song P; Wang AJ; Zhao T; Feng JJ Biomater Adv; 2024 Sep; 162():213919. PubMed ID: 38861801 [TBL] [Abstract][Full Text] [Related]
15. A multifunctional cascade bioreactor based on a layered double oxides composite hydrogel for synergetic tumor chemodynamic/starvation/photothermal therapy. Xu R; Zhang D; Tan J; Ge N; Liu D; Liu J; Ouyang L; Zhu H; Qiao Y; Qiu J; Zhu S; Liu X Acta Biomater; 2022 Nov; 153():494-504. PubMed ID: 36115653 [TBL] [Abstract][Full Text] [Related]
16. Degradable Tumor-Responsive Iron-Doped Phosphate-Based Glass Nanozyme for H Yao Y; Wang Z; Cao Q; Li H; Ge S; Liu J; Sun P; Liu Z; Wu Y; Wang W; Liu J ACS Appl Mater Interfaces; 2022 Apr; 14(15):17153-17163. PubMed ID: 35394283 [TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanoplatform upregulates tumor microenvironment acidity for enhanced cancer therapy via synergistic induction of apoptosis, ferroptosis, and anti-angiogenesis. Zhang C; Wang P; Zhang YN; Lu P; Huang X; Wang Y; Ran L; Xin H; Xu X; Gao W; Sun Y; Zhang L; Zhang G J Nanobiotechnology; 2023 Feb; 21(1):59. PubMed ID: 36810074 [TBL] [Abstract][Full Text] [Related]
18. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis. Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683 [TBL] [Abstract][Full Text] [Related]
19. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects. An G; Zheng H; Guo L; Huang J; Yang C; Bai Z; Wang N; Yang W; Zhu Y J Colloid Interface Sci; 2024 May; 662():298-312. PubMed ID: 38354557 [TBL] [Abstract][Full Text] [Related]